Figure 2.
Flow of patients through the study. *n is for the primary efficacy analysis population; n may differ for the efficacy population for other outcome measures. AE, adverse event; PK, pharmacokinetics.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.